By Adriano Marchese Teva Pharmaceutical Industries said Wednesday its loss in 2022 was deeper after discovering errors related to estimated future royalty.
By Adriano Marchese Teva Pharmaceutical Industries on Wednesday reported a swing-to-a-profit in the fourth quarter, with revenue beating expectations, and.
By Adriano Marchese Shares of Teva Pharmaceutical Industries were trading higher on Wednesday after the company reported better-than-expected revenue and.
By Sabela Ojea Exelixis said the Opposition Division of the European Patent Office ruled in favor of its patent for tablet formulations of cabozantinib, a.